Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
28.42
Dollar change
-0.53
Percentage change
-1.83
%
IndexRUT P/E- EPS (ttm)-1.83 Insider Own58.06% Shs Outstand130.33M Perf Week-7.94%
Market Cap4.13B Forward P/E- EPS next Y-1.87 Insider Trans-0.25% Shs Float60.93M Perf Month4.60%
Income-243.45M PEG- EPS next Q-0.43 Inst Own47.50% Short Float15.24% Perf Quarter-25.91%
Sales0.00M P/S- EPS this Y-4.71% Inst Trans5.05% Short Ratio8.64 Perf Half Y-14.96%
Book/sh4.68 P/B6.07 EPS next Y-4.20% ROA-41.70% Short Interest9.29M Perf Year34.88%
Cash/sh4.76 P/C5.98 EPS next 5Y3.69% ROE-44.51% 52W Range18.16 - 45.58 Perf YTD-32.54%
Dividend Est.- P/FCF- EPS past 5Y- ROI-35.84% 52W High-37.65% Beta0.74
Dividend TTM- Quick Ratio22.14 Sales past 5Y0.00% Gross Margin- 52W Low56.48% ATR (14)1.23
Dividend Ex-Date- Current Ratio22.14 EPS Y/Y TTM-10.48% Oper. Margin0.00% RSI (14)40.86 Volatility3.99% 4.16%
Employees164 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.06 Target Price50.87
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q27.65% Payout- Rel Volume0.91 Prev Close28.95
Sales Surprise- EPS Surprise33.09% Sales Q/Q- EarningsFeb 12 BMO Avg Volume1.07M Price28.42
SMA20-3.78% SMA50-5.42% SMA200-13.57% Trades Volume981,099 Change-1.83%
Date Action Analyst Rating Change Price Target Change
Mar-28-24Initiated Oppenheimer Outperform $50
Mar-13-24Initiated Goldman Buy $50
Feb-20-24Initiated JP Morgan Overweight $51
Feb-15-24Initiated Wolfe Research Outperform $55
Dec-12-23Initiated Deutsche Bank Buy $50
Oct-13-23Upgrade UBS Neutral → Buy $18 → $55
Sep-26-23Upgrade Raymond James Mkt Perform → Outperform $40
May-01-23Initiated BofA Securities Buy $26
Apr-25-23Initiated Citigroup Buy $28
Mar-31-23Initiated Piper Sandler Overweight $28
May-27-24 06:28PM
May-13-24 09:55AM
May-08-24 02:43AM
Apr-24-24 11:33AM
07:39AM
11:53AM Loading…
Apr-22-24 11:53AM
Apr-17-24 12:00PM
Mar-25-24 03:00PM
Mar-21-24 04:45PM
11:31AM
Mar-17-24 05:20PM
Mar-14-24 07:04AM
Mar-13-24 11:30AM
Mar-12-24 07:30AM
Mar-08-24 09:35AM
03:04PM Loading…
Feb-26-24 03:04PM
Feb-23-24 11:22PM
Feb-14-24 04:35AM
12:29AM
Feb-13-24 07:26AM
Feb-12-24 07:00AM
Feb-06-24 02:38PM
Jan-22-24 06:07AM
Jan-19-24 04:39PM
Jan-13-24 03:02AM
Jan-03-24 08:00AM
Dec-26-23 10:01AM
Dec-21-23 04:09PM
11:00AM
10:57AM
06:49AM Loading…
06:49AM
Dec-20-23 04:30PM
04:30PM
Dec-19-23 10:16AM
Dec-01-23 01:01AM
Nov-29-23 10:22AM
Nov-28-23 07:00AM
07:00AM
Nov-25-23 11:03AM
Nov-14-23 12:30AM
Nov-13-23 08:00AM
Nov-10-23 07:19AM
Nov-09-23 08:17AM
07:00AM
Oct-27-23 11:02PM
Oct-13-23 09:50AM
Oct-11-23 11:01PM
Oct-07-23 01:00AM
Oct-05-23 03:01AM
Oct-02-23 04:52PM
Sep-28-23 09:58AM
Sep-27-23 11:41PM
04:09PM
04:06PM
12:25PM
12:21PM
09:25AM
Sep-26-23 05:00PM
04:13PM
04:06PM
03:23PM
02:26PM
10:01AM
09:10AM
06:00AM
Sep-25-23 11:01PM
Aug-17-23 09:31AM
Aug-12-23 08:25AM
Aug-11-23 11:20AM
Aug-10-23 07:00AM
Aug-09-23 06:26AM
Aug-01-23 10:00AM
Jul-03-23 09:00AM
Jul-01-23 09:00AM
Jun-29-23 01:42AM
Jun-21-23 11:30AM
May-23-23 09:48AM
06:05AM
May-22-23 07:00AM
Apr-05-23 01:45PM
Feb-15-23 01:14PM
Feb-03-23 07:00AM
Dec-29-22 11:04AM
Dec-19-22 07:53AM
Dec-16-22 08:06AM
Dec-15-22 09:40AM
Dec-12-22 03:44PM
Nov-25-22 09:40AM
Nov-24-22 11:04AM
Nov-17-22 10:38AM
Nov-09-22 09:40AM
Nov-07-22 01:34PM
08:00AM
Nov-04-22 07:00AM
Oct-20-22 01:56PM
Oct-09-22 10:57AM
Oct-06-22 03:52PM
Oct-04-22 08:45AM
Sep-29-22 02:36PM
Sep-28-22 10:45AM
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salzmann PeterChief Executive OfficerMay 22 '24Sale29.6516,163479,2331,036,716May 24 04:15 PM
Barnett Eva ReneeChief Financial OfficerMay 22 '24Sale29.654,042119,845355,414May 24 04:18 PM
Butchko Julia G.Chief Development OfficerMay 22 '24Sale29.653,24796,274448,380May 24 04:14 PM
Macias William L.Chief Medical OfficerMay 22 '24Sale29.653,24796,274374,403May 24 04:13 PM
Levine Mark S.Chief Legal OfficerMay 22 '24Sale29.653,24296,125339,914May 24 04:10 PM
Stout Jay SChief Technology OfficerApr 24 '24Sale28.907,239209,207147,739Apr 26 05:20 PM
Levine Mark S.Chief Legal OfficerApr 24 '24Sale28.903,963114,531343,156Apr 26 05:18 PM
Geffner MichaelChief Medical OfficerApr 24 '24Sale28.903,26194,243141,616Apr 26 05:22 PM
Salzmann PeterChief Executive OfficerApr 17 '24Sale29.0634,079990,2691,052,879Apr 19 05:57 PM
Barnett Eva ReneeChief Financial OfficerApr 17 '24Sale29.0612,253356,049359,456Apr 19 06:01 PM
Butchko Julia G.Chief Development OfficerApr 17 '24Sale29.0610,115293,923451,627Apr 19 05:59 PM
Levine Mark S.Chief Legal OfficerApr 17 '24Sale29.069,827285,554347,119Apr 19 06:06 PM
Macias William L.Chief Medical OfficerApr 17 '24Sale29.068,280240,602377,650Apr 19 06:05 PM
Salzmann PeterChief Executive OfficerApr 09 '24Sale31.184,807149,8821,086,958Apr 10 04:14 PM
Barnett Eva ReneeChief Financial OfficerApr 09 '24Sale31.183,689115,023371,709Apr 10 04:18 PM
Butchko Julia G.Chief Development OfficerApr 09 '24Sale31.181,05332,833461,742Apr 10 04:16 PM
Salzmann PeterChief Executive OfficerFeb 22 '24Sale36.1513,454486,362931,231Feb 23 04:11 PM
Barnett Eva ReneeChief Financial OfficerFeb 22 '24Sale36.152,930105,920320,420Feb 23 04:21 PM
Macias William L.Chief Medical OfficerFeb 22 '24Sale36.152,22180,289330,952Feb 23 04:16 PM
Butchko Julia G.Chief Development OfficerFeb 22 '24Sale36.152,14677,578407,817Feb 23 04:14 PM
Levine Mark S.Chief Legal OfficerFeb 22 '24Sale36.152,13477,144301,968Feb 23 04:18 PM
Geffner MichaelChief Medical OfficerJan 26 '24Sale37.9210,101383,01289,899Jan 29 04:11 PM
Levine Mark S.Chief Legal OfficerJan 26 '24Sale37.923,027114,778304,102Jan 29 04:12 PM
Macias William L.Chief Medical OfficerJan 18 '24Sale41.0342417,397333,173Jan 19 04:04 PM
Barnett Eva ReneeChief Financial OfficerJan 11 '24Sale41.833,515147,023323,350Jan 12 04:34 PM
Salzmann PeterChief Executive OfficerJan 05 '24Sale38.593,824147,568944,685Jan 09 04:18 PM
Butchko Julia G.Chief Development OfficerJan 05 '24Sale38.591,29750,051409,963Jan 09 04:20 PM
MIGAUSKY GEORGE VDirectorDec 01 '23Sale39.7312,700504,567109,808Dec 05 04:25 PM
Fromkin Andrew J.DirectorDec 01 '23Sale39.7312,350490,69788,658Dec 05 04:30 PM
Pande AtulDirectorDec 01 '23Sale39.7312,350490,66783,158Dec 05 04:28 PM
Salzmann PeterChief Executive OfficerNov 22 '23Sale32.7816,217531,581948,509Nov 24 02:55 PM
Barnett Eva ReneeChief Financial OfficerNov 22 '23Sale32.784,055132,920326,865Nov 24 02:51 PM
Butchko Julia G.Chief Development OfficerNov 22 '23Sale32.783,265107,024411,260Nov 24 02:47 PM
Macias William L.Chief Medical OfficerNov 22 '23Sale32.783,265107,024333,597Nov 24 02:45 PM
Levine Mark S.Chief Legal OfficerNov 22 '23Sale32.783,252106,598307,129Nov 24 02:41 PM
Levine Mark S.Chief Legal OfficerOct 25 '23Sale34.664,107142,349310,381Oct 27 04:04 PM
Macias William L.Chief Medical OfficerOct 19 '23Sale36.8053019,504336,862Oct 20 04:06 PM
Barnett Eva ReneeChief Financial OfficerOct 10 '23Sale36.924,557168,244330,920Oct 11 04:11 PM
Salzmann PeterChief Executive OfficerOct 05 '23Sale36.245,239189,887964,726Oct 06 05:10 PM
Butchko Julia G.Chief Development OfficerOct 05 '23Sale36.241,73562,885414,525Oct 06 05:15 PM
Roivant Sciences Ltd.DirectorOct 02 '23Buy38.001,526,31658,000,00879,805,331Oct 04 05:15 PM
Salzmann PeterChief Executive OfficerAug 30 '23Sale22.0256,7741,250,338969,965Sep 01 04:08 PM
Barnett Eva ReneeChief Financial OfficerAug 24 '23Sale20.3014,386292,036335,477Aug 25 05:03 PM
Macias William L.Chief Medical OfficerAug 24 '23Sale20.3012,333250,360337,392Aug 25 04:57 PM
Butchko Julia G.Chief Development OfficerAug 24 '23Sale20.3012,333250,360416,260Aug 25 05:00 PM
Levine Mark S.Chief Legal OfficerAug 24 '23Sale20.3012,286249,406314,488Aug 25 05:05 PM
Salzmann PeterChief Executive OfficerAug 14 '23Sale21.42103,0582,207,1781,026,739Aug 16 04:11 PM
Salzmann PeterChief Executive OfficerAug 07 '23Sale21.73101,3392,202,0961,129,797Aug 08 04:44 PM
Levine Mark S.Chief Legal OfficerJul 26 '23Sale21.633,91784,725326,774Jul 27 04:33 PM
Barnett Eva ReneeChief Financial OfficerJul 19 '23Sale24.942,72567,962349,863Jul 20 04:35 PM
Macias William L.Chief Medical OfficerJul 19 '23Sale24.9442610,624349,725Jul 20 04:37 PM
Salzmann PeterChief Executive OfficerJul 12 '23Sale19.733,23363,7871,231,136Jul 13 05:11 PM
Butchko Julia G.Chief Development OfficerJul 12 '23Sale19.731,47029,003428,593Jul 13 05:10 PM